Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:30 pm Purchase | 2025-09-30 | 13G | Relay Therapeutics, Inc. RLAY | Commodore Capital LP | 17,000,000 9.900% | 3,650,000 (+27.34%) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-06-30 | 13G | Relay Therapeutics, Inc. RLAY | Commodore Capital LP | 13,350,000 7.800% | 3,350,000 (+33.50%) | Filing History |
| 2025-08-14 4:56 pm Purchase | 2025-06-30 | 13G | Relay Therapeutics, Inc. RLAY | Point72 Asset Management, L.P. | 13,445,704 7.800% | 3,751,487 (+38.70%) | Filing History |
| 2025-07-29 2:22 pm Sale | 2025-06-30 | 13G | Relay Therapeutics, Inc. RLAY | The Vanguard Group | 9,379,851 5.470% | -2,725,569 (-22.52%) | Filing History |
| 2025-05-15 4:05 pm Purchase | 2025-05-08 | 13G | Relay Therapeutics, Inc. RLAY | Commodore Capital LP | 10,000,000 5.800% | 10,000,000 (New Position) | Filing History |
| 2025-04-30 11:12 am Purchase | 2025-03-31 | 13G | Relay Therapeutics, Inc. RLAY | The Vanguard Group | 12,105,420 7.140% | 1,455,033 (+13.66%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 10,308,012 6.100% | -4,366,250 (-29.75%) | Filing History |
| 2025-03-20 6:13 pm Purchase | 2025-03-14 | 13G | Relay Therapeutics, Inc. RLAY | Point72 Asset Management, L.P. | 9,694,217 5.700% | 9,694,217 (New Position) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 14,674,262 8.800% | 5,100,839 (+53.28%) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | Relay Therapeutics, Inc. RLAY | T. Rowe Price Associates, Inc. | 5,280,291 3.300% | -3,309,134 (-38.53%) | Filing History |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | Casdin Capital LLC | 7,387,943 5.990% | 1,089,369 (+17.30%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | T. Rowe Price Associates, Inc. | 8,589,425 7.000% | 8,589,425 (New Position) | Filing History |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | Relay Therapeutics, Inc. RLAY | The Vanguard Group | 10,650,387 8.640% | 266,169 (+2.56%) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 9,573,423 7.800% | 1,575,438 (+19.70%) | Filing History |
| 2024-01-23 09:35 am Sale | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | STATE STREET CORP STT | 4,903,578 3.980% | -1,360,919 (-21.72%) | Filing History |
| 2023-10-02 4:14 pm Purchase | 2023-09-21 | 13G | Relay Therapeutics, Inc. RLAY | Casdin Capital LLC | 6,298,574 5.160% | 6,298,574 (New Position) | Filing History |
| 2023-07-10 10:20 am Sale | 2023-07-07 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 2,956,221 2.430% | -6,777,627 (-69.63%) | Filing History |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 9,733,848 8.051% | -2,224,364 (-18.60%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Relay Therapeutics, Inc. RLAY | The Vanguard Group | 10,384,218 8.590% | 4,185,776 (+67.53%) | Filing History |
| 2023-02-03 3:11 pm Purchase | 2022-12-31 | 13G | Relay Therapeutics, Inc. RLAY | STATE STREET CORP STT | 6,264,497 5.180% | 6,264,497 (New Position) | Filing History |